{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:53:30Z","timestamp":1791212010051,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 3","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To compare the outcomes of three different therapeutic modalities in acute adenoviral conjunctivitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Prospective randomized study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 65 eyes of 65 patients with nested polymerase chain reaction (PCR)-proven adenoviral conjunctivitis were enrolled. The control group (20 eyes) received carbomer gel, whereas the treatment group (15 eyes each) received group 1: Ganciclovir (0.15%) gel five times\/day and dexamethasone 0.1% four times\/day; group 2: Povidone\u2013iodine (PVP-I) 1% four times\/day, and dexamethasone 0.1% four times\/day; group 3: PVP-I 1% four times\/day, ganciclovir 0.15% five times\/day, and dexamethasone 0.1% four times\/day in addition to the standard of care. Patients presenting within the first 96 hours were recruited, and antiviral treatment was given for seven days in all groups. The clinical signs and symptoms, as well as the viral load, were documented at enrollment, day 7, and day 14. All the symptoms and signs were graded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Group 3 performed significantly better in terms of foreign body sensation (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.013), pain (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.019), and conjunctival congestion (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.00) compared with all the groups at day 7. The control group had a significantly higher number of subepithelial infiltrates (SEIs) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001) and pseudomembranes (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.035) at day 7 than all the other groups. The viral load reduction was variable in all patients in all the groups; thus, a correlation could not be achieved.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The combination of PVP-I 1% and ganciclovir 0.15% with dexamethasone 0.1% significantly reduced the severity of signs and symptoms in adenoviral conjunctivitis. The addition of dexamethasone was safe and effective in decreasing the incidence of SEI\u2019s and pseudomembranes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_1019_25","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:00:11Z","timestamp":1787554811000},"page":"S379-S385","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A prospective, randomized study comparing different therapeutic modalities for acute adenoviral conjunctivitis"],"prefix":"10.4103","volume":"74","author":[{"given":"Anchal","family":"Thakur","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya P","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Virology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Virology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mini P","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Virology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirbhai","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.K","family":"Ratho","sequence":"additional","affiliation":[{"name":"Department of Virology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chintan","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"R1-20261005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.survophthal.2015.04.001","article-title":"Adenoviral keratoconjunctivitis","volume":"60","author":"Jhanji","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"R2-20261005","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1185\/03007990903038269","article-title":"Acute conjunctivitis: Truth and misconceptions","volume":"25","author":"O\u2019Brien","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R3-20261005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/09273948.2010.498658","article-title":"Cellular and tissue architecture of conjunctival membranes in epidemic keratoconjunctivitis","volume":"18","author":"Chintakuntlawar","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"R4-20261005","doi-asserted-by":"crossref","first-page":"P134","DOI":"10.1016\/j.ophtha.2023.12.037","article-title":"Conjunctivitis Preferred Practice Pattern\u00ae","volume":"131","year":"2024","journal-title":"Ophthalmology."},{"key":"R5-20261005","first-page":"315","article-title":"Anti-adenoviral effects of ganciclovir in types inducing keratoconjunctivitis by quantitative polymerase chain reaction methods","volume":"8","author":"Huang","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"R6-20261005","article-title":"Ganciclovir effects in conjunctivitis","author":"Tabbara","year":"2001","journal-title":"Presented at ARVO Annual Meeting abstracts"},{"key":"R7-20261005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1590\/S0004-27492011000600007","article-title":"Ganciclovir 0.15% ophthalmic gel in the treatment of adenovirus keratoconjunctivitis","volume":"74","author":"Yabiku","year":"2011","journal-title":"Arq Bras Oftalmol"},{"key":"R8-20261005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1167\/iovs.10-5944","article-title":"Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis","volume":"52","author":"Clement","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-20261005","first-page":"30","article-title":"The ocular application of povidone-iodine","volume":"16","author":"Isenberg","year":"2003","journal-title":"Community Eye Health"},{"key":"R10-20261005","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12325-009-0062-1","article-title":"A combination of povidone-iodine 0.4% and dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis","volume":"26","author":"Pelletier","year":"2009","journal-title":"Adv Ther"},{"key":"R11-20261005","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jtos.2019.08.005","article-title":"Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study","volume":"17","author":"Shorter","year":"2019","journal-title":"Ocul Surf"},{"key":"R12-20261005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ajo.2018.08.056","article-title":"Randomized, controlled, phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis","volume":"197","author":"Cinal","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R13-20261005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0928-0197(98)00021-X","article-title":"Development and use of nested polymerase chain reaction (PCR) for the detection of adenovirus from conjunctivitis specimens","volume":"11","author":"Dalapathy","year":"1998","journal-title":"J Clin Virol"},{"key":"R14-20261005","first-page":"260","article-title":"Isolation of a variant human adenovirus identified based on phylogenetic analysis during an outbreak of acute keratoconjunctivitis in Chennai","volume":"136","author":"Janani","year":"2012","journal-title":"Indian J Med Res"},{"key":"R15-20261005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00003226-200108000-00020","article-title":"Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand White rabbit","volume":"20","author":"Romanowski","year":"2001","journal-title":"Cornea"},{"issue":"Suppl 2","key":"R16-20261005","first-page":"29","article-title":"Inactivation of human viruses by povidone-iodine in comparison with other antiseptics","volume":"195","author":"Kawana","year":"1997","journal-title":"Dermatology"},{"key":"R17-20261005","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/JVI.80.7.3549-3558.2006","article-title":"Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species","volume":"80","author":"Jogler","year":"2006","journal-title":"J Virol"},{"key":"R18-20261005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7883\/yoken.JJID.2022.210","article-title":"The relationship between clinical findings and viral load in adenoviral keratoconjunctivitis","volume":"75","author":"Isik","year":"2022","journal-title":"Jpn J Infect Dis"},{"key":"R19-20261005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/v13020293","article-title":"Adenovirus and the cornea: More than meets the eye","volume":"13","author":"Rajaiya","year":"2021","journal-title":"Viruses"},{"key":"R20-20261005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jmv.20440","article-title":"Evidence for persistence of adenovirus in the tear film a decade following conjunctivitis","volume":"77","author":"Kaye","year":"2005","journal-title":"J Med Virol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1019_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:01:31Z","timestamp":1791208891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1019_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":20,"journal-issue":{"issue":"Suppl 3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1019_25","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"2025-04-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}